Alt5 Sigma executives scheduled to appear on CNBC’s Squawk Box Tuesday

Published 12/08/2025, 12:56
Alt5 Sigma executives scheduled to appear on CNBC’s Squawk Box Tuesday

Alt5 Sigma Corp (NASDAQ:ALTS) announced that incoming board observer Zak Folkman and incoming Chairman of the Board Zach Witkolf are scheduled to appear on CNBC’s “Squawk Box” on Tuesday, beginning as early as 7:45 a.m. EST. The company disclosed the planned media appearance in a statement included in a regulatory filing with the U.S. Securities and Exchange Commission.

According to the filing, the representatives may discuss Alt5 Sigma’s treasury strategy, which includes a focus on acquiring WLFI tokens and integrating USD1 into its broader financial ecosystem. The company indicated that the discussion may also touch on efforts to position Alt5 Sigma in the area of institutional-grade cryptocurrency payment solutions and to expand access to stablecoin technology.

The filing states that Folkman and Witkolf may address how Alt5 Sigma provides services designed to connect cryptocurrency with everyday financial use, as well as expectations regarding integration with USD1 to enhance its suite of payment services.

Alt5 Sigma’s common stock is listed on The Nasdaq Stock Market LLC under the ticker symbol ALTS. The company is incorporated in Nevada and operates in the pharmaceutical preparations sector.

The information is based on a statement included in the company’s Form 8-K filed with the SEC.

In other recent news, ALT5 Sigma Corporation has entered into agreements for the issuance and sale of up to 200 million shares of common stock, aiming to raise approximately $1.5 billion. This capital is being raised through a combination of registered direct and private placement offerings, with World Liberty Financial, Inc. acting as the lead investor in the private placement. Additionally, ALT5 Sigma has completed the integration of its ALT5 Prime FIX API with Fundamental Interaction’s trading technology, facilitating access to digital asset markets for broker-dealers and Alternative Trading Systems.

ALT5 Sigma has also expressed its support for the newly signed GENIUS Act, which provides regulatory guidelines for stablecoin issuance and oversight in the United States. The company’s CEO, Peter Tassiopoulos, described the legislation as a significant milestone for U.S. enterprises. In a recent development, David Danziger has been appointed to the board following the passing of longtime director Richard Butler, who had served since 2015. Furthermore, ALT5 Sigma has been added to the Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.